{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:13Z","timestamp":1786119493717,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/mbc.0b013e32833c2bb5","type":"journal-article","created":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T06:16:31Z","timestamp":1284012991000},"page":"615-619","source":"Crossref","is-referenced-by-count":14,"title":["The use of desmopressin in mild hemophilia A"],"prefix":"10.1097","volume":"21","author":[{"given":"Massimo","family":"Franchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zaffanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl. 1","key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2516.2000.00059.x","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years","volume":"6","author":"Mannucci","year":"2000","journal-title":"Haemophilia"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ajh.20940","article-title":"The use of desmopressin as a hemostatic agent","volume":"82","author":"Franchini","year":"2007","journal-title":"Am J Hematol"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0268-960X(91)90032-8","article-title":"Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease","volume":"5","author":"Rodeghiero","year":"1991","journal-title":"Blood Rev"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2007.01606.x","article-title":"Desmopressin for the treatment of haemophilia","volume":"14","author":"Castaman","year":"2008","journal-title":"Haemophilia"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","article-title":"Mechanisms of plasminogen activator and factor VIII increase after vasoactive drugs","volume":"30","author":"Mannucci","year":"1975","journal-title":"Br J Haematol"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1538-7836.2003.00190.x","article-title":"Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pbc.20658","article-title":"Regulated release of VWF and FVIII and the biologic implications","volume":"46","author":"Haberichter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2257.1984.tb00548.x","article-title":"Evaluation of the effectiveness of DDAVP in surgery and bleeding episodes in hemophilia and von Willebrand disease: a study of 43 patients","volume":"6","author":"Mariani","year":"1984","journal-title":"Clin Lab Haematol"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-103-1-6","article-title":"Response of patients with mild and moderate hemophilia A and von Willebrand disease to treatment with desmopressin","volume":"103","author":"de la Fuente","year":"1985","journal-title":"Ann Intern Med"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2141.2002.03507.x","article-title":"DDAVP challenge tests in boys with mild\/moderate haemophilia A","volume":"117","author":"Revel-Vilk","year":"2002","journal-title":"Br J Haematol"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2003-37944","article-title":"Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety","volume":"29","author":"Lethagen","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2516.2002.00645.x","article-title":"The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents","volume":"8","author":"Villar","year":"2002","journal-title":"Haemophilia"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2141.2000.02067.x","article-title":"Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders","volume":"109","author":"Nolan","year":"2000","journal-title":"Br J Haematol"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1055\/s-0038-1646051","article-title":"Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses","volume":"58","author":"Mannucci","year":"1987","journal-title":"Thromb Haemost"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/s-0038-1646050","article-title":"Intranasal and intravenous administration of desmopressin: effect on FVIII\/vWF, pharmacokinetics and reproducibility","volume":"58","author":"Lethagen","year":"1987","journal-title":"Thromb Haemost"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01720274","article-title":"Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I","volume":"60","author":"Lethagen","year":"1990","journal-title":"Blut"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","article-title":"Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)","volume":"82","author":"Mannucci","year":"2009","journal-title":"Br J Haematol"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830310310","article-title":"Hyponatremia and seizures in young children given DDAVP","volume":"31","author":"Smith","year":"1989","journal-title":"Am J Hematol"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJM198801143180215","article-title":"Myocardial infarction in a patient with hemophilia treated with DDAVP","volume":"318","author":"Bond","year":"1988","journal-title":"N Engl J Med"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1055\/s-0037-1614294","article-title":"Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin","volume":"92","author":"Virtanen","year":"2004","journal-title":"Thromb Haemost"},{"key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2141.2009.08005.x","article-title":"Co-morbidities and quality of life in elderly persons with hemophilia.","volume":"148","author":"Franchini","year":"2010","journal-title":"Br J Haematol"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1538-7836.2009.03595.x","article-title":"Molecular and phenotypic determinants of response to desmopressin in adult patients with mild hemophilia A","volume":"7","author":"Castaman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1538-7836.2009.03468.x","article-title":"Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy","volume":"7","author":"Riccardi","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3476(83)80526-5","article-title":"DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease","volume":"102","author":"Warrier","year":"1983","journal-title":"J Pediatr"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0049-3848(88)90316-7","article-title":"Clinical evaluation of subcutaneously administered DDAVP","volume":"49","author":"Ghirardini","year":"1988","journal-title":"Thromb Res"},{"key":"R30-1-20210203","first-page":"273","article-title":"Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency","volume":"21","author":"Chistolini","year":"1991","journal-title":"Haemostasis"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-114-7-563","article-title":"Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease","volume":"114","author":"Rose","year":"1991","journal-title":"Ann Intern Med"},{"key":"R32-1-20210203","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero","year":"1996","journal-title":"Thromb Haemost"},{"key":"R33-1-20210203","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-126-9-199705010-00031","article-title":"Desmopressin nasal spray for hemophilia A and type I von Willebrand disease","volume":"126","author":"Seremetis","year":"1997","journal-title":"Ann Intern Med"},{"key":"R34-1-20210203","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2516.2001.00500.x","article-title":"High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A","volume":"7","author":"Leissinger","year":"2001","journal-title":"Haemophilia"},{"key":"R35-1-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01738476","article-title":"Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors","volume":"66","author":"Lethagen","year":"1993","journal-title":"Ann Hematol"},{"key":"R36-1-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00043426-199801000-00005","article-title":"Mild hemophilia in children: prevalence, complications, and treatment","volume":"20","author":"Venkateswaran","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"R37-1-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1538-7836.2009.03717.x","article-title":"Mild hemophilia A.","volume":"8","author":"Franchini","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R38-1-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/s-0037-1615061","article-title":"Factor VIII inhibitors in mild and moderate-severity haemophilia A: UK Haemophilia Centre Directors Organisation","volume":"79","author":"Hay","year":"1998","journal-title":"Thromb Haemost"},{"key":"R39-1-20210203","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ajh.1176","article-title":"Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy","volume":"68","author":"Robbins","year":"2001","journal-title":"Am J Hematol"},{"key":"R40-1-20210203","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1538-7836.2006.01820.x","article-title":"Can we prevent inhibitors in mild and moderate factor VIII-deficient patients?","volume":"4","author":"Aledort","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R41-1-20210203","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1647493","article-title":"Bleeding symptoms in carriers of hemophilia A and B","volume":"59","author":"Mauser Bunschoten","year":"1988","journal-title":"Thromb Haemost"},{"key":"R42-1-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"key":"R43-1-20210203","first-page":"1","article-title":"Symptomatic carriers of hemophilia: treatment of hemophilia monograph","volume":"46","author":"Mauser-Bunschoten","year":"2008","journal-title":"World Federation of Hemophilia"},{"key":"R44-1-20210203","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00006254-199807000-00025","article-title":"DDAVP use during pregnancy: an analysis of its safety for mother and child","volume":"53","author":"Ray","year":"1998","journal-title":"Obstet Gynecol Surv"},{"key":"R45-1-20210203","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2004-11-4472","article-title":"Use of desmopressin (DDAVP) during early pregnancy in FVIII-deficient women","volume":"105","author":"Mannucci","year":"2005","journal-title":"Blood"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201010000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:49Z","timestamp":1786041589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201010000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32833c2bb5","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}